Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Choosing CCR5 or Rev siRNA in HIV-1.

× No keyword cloud information.

11 in total

1. Induction of interleukins IL-6 and IL-8 by siRNA.

Authors: E Pauls; J Senserrich; M Bofill; B Clotet; J A Esté
Journal: Clin Exp Immunol Date: 2007-01 Impact factor: 4.330

2. Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.

Authors: Dong-Seong Lee; Kyeong-Eun Jung; Cheol-Hee Yoon; Hong Lim; Yong-Soo Bae
Journal: Antimicrob Agents Chemother Date: 2005-10 Impact factor: 5.191

3. Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.

Authors: Maria E Cardona; Jorma Hinkula; Kristin Gustafsson; Birger Christensson; Britta Wahren; Abdalla J Mohamed; C I Edvard Smith; H Jose Arteaga
Journal: Mol Biol Rep Date: 2022-09-12 Impact factor: 2.742

4. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.

Authors: Saki Shimizu; Patrick Hong; Balamurugan Arumugam; Lauren Pokomo; Joshua Boyer; Naoya Koizumi; Panyamol Kittipongdaja; Angela Chen; Greg Bristol; Zoran Galic; Jerome A Zack; Otto Yang; Irvin S Y Chen; Benhur Lee; Dong Sung An
Journal: Blood Date: 2009-12-17 Impact factor: 22.113

5. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.

Authors: Atze T Das; Thijn R Brummelkamp; Ellen M Westerhout; Monique Vink; Mandy Madiredjo; René Bernards; Ben Berkhout
Journal: J Virol Date: 2004-03 Impact factor: 5.103

6. Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus.

Authors: Bryce Chackerian; Lindsey Briglio; Paul S Albert; Douglas R Lowy; John T Schiller
Journal: J Virol Date: 2004-04 Impact factor: 5.103

Choosing CCR5 or Rev siRNA in HIV-1.

1. Induction of interleukins IL-6 and IL-8 by siRNA.

2. Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.

3. Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.

4. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.

5. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.

6. Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus.

Review 7. Oligonucleotide-based antiviral strategies.

Review 8. The therapeutic potential of RNA interference.

9. Design and application of a versatile expression vector for RNAi in mammalian cells.

10. A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models.